Improving Cognition via Exercise (ICE): Study Protocol for a Multi-Site, Parallel-Group, Single-Blind, Randomized Clinical Trial Examining the Efficacy of Aerobic Exercise to Improve Neurocognition, Daily Functioning, and Biomarkers of Cognitive Change in-Journal of Psychiatry and Brain Science-CSCIED科技核心评价数据库-手机版

Improving Cognition via Exercise (ICE): Study Protocol for a Multi-Site, Parallel-Group, Single-Blind, Randomized Clinical Trial Examining the Efficacy of Aerobic Exercise to Improve Neurocognition, Daily Functioning, and Biomarkers of Cognitive Change in

ES评分 0 浏览量：623 下载量：0

全文阅读下载引用收藏

DOI	10.20900/jpbs.20190020
刊名	Journal of Psychiatry and Brain Science JPBS
年，卷(期)	2019, 4(6)
作者	Luz H. Ospina,Melanie Wall,Lars F. Jarskog,Jacob S. Ballon,Joseph McEvoy,Matthew N. Bartels,Richard Buchsbaum,Richard P. Sloan,T. Scott Stroup,David Kimhy*,
作者单位
Abstract	Individuals with schizophrenia (SZ) display cognitive deficits that have been identified as major determinants of poor functioning and disability, representing a serious public health concern and an important target for interventions. At present, available treatments offer only minimal to moderate benefits to ameliorate cognitive deficits. Thus, there remains an urgent need to identify novel interventions to improve cognition in people with SZ. Emerging evidence from animal and basic human research suggests aerobic exercise training (AE) has beneficial effects on cognition. Preliminary findings suggest that AE is efficacious in improving cognitive functioning in SZ, however the extant studies have been limited by small samples, a dearth of information on biologically-relevant covariates, and limited information on impact on daily functioning. Additionally, while AE-related cognitive benefits have been linked to Brain-Derived Neurotrophic Factor (BDNF) upregulation, this putative mechanism needs confirmation. The present report describes a study protocol designed to address these limitations—we review and summarize the current literature on treatment of cognitive deficits in SZ, state the rationale for employing AE to target these deficits, and describe the current protocol—a multi-site, single-blind, randomized clinical trial aiming to recruit 200 community-dwelling individuals with SZ. Participants are randomized to one of two 12-week interventions: AE using active-play video games (i.e., Xbox Kinect) and traditional cardiovascular exercise equipment or a stretching-and-toning (ST) control intervention. Participants undergo assessments of aerobic fitness, cognition, and daily functioning, as well as BDNF and other biomarkers of cognitive change, at baseline and after 6- and 12-weeks.
KeyWord	schizophrenia; cognition; functioning; aerobic exercise; aerobic fitness; BDNF; neurotrophins; inflammation; neuroplasticity
基金项目
页码	-

参考文献
相关文献

1.Green MF, Kern RS, Heaton RK. Longitudinal studies of cognition and functional outcome in schizophrenia: Implications for MATRICS. Schizophr Res. 2004;72(1):41-51.

2.Green MF, Nuechterlein KH, Gold JM, Barch DM, Cohen J, Essock S, et al. Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry. 2004 Sep 1;56(5):301-7.

3.Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK. Identification of separable cognitive factors in schizophrenia. Schizophr Res. 2004;72(1):29-39.

4.Gold JM. Cognitive deficits as treatment targets in schizophrenia. Schizophr Res. 2004;72(1):21-8.

5.Mehta UM, Thirthalli J, Subbakrishna DK, Gangadhar BN, Eack SM, Keshavan MS. Social and neuro-cognition as distinct cognitive factors in schizophrenia: A systematic review. Schizophr Res. 2013;148(1-3):3-11. doi: 10.1016/j.schres.2013.05.009

6.Palmer BW, Heaton RK, Kuck J, Braff D, Paulsen JS, Jackuelyn Harris M, et al. Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology. 1997;11(3):437-46.

7.Keefe RSE. Cognitive deficits in patients with schizophrenia: Effects and treatment. J Clin Psychiatry. 2007;68(Suppl 14):8-13.

8.Green MF. Stimulating the Development of Drug Treatments to Improve Cognition in Schizophrenia. Annu Rev Clin Psychol. 2007;3:159-80.

9.Green MF. Cognition, drug treatment, and functional outcome in schizophrenia: A tale of two transitions. Am J Psychiatry. 2007;164(7):992-4.

10.Vinogradov S, Fisher M, Nagarajan S. Cognitive Training in Schizophrenia: Golden Age or Wild West? Biol Psychiatry. 2013;73(10):935-7. doi: 10.1016/j.biopsych.2013.03.015

11.Breier A. Developing drugs for cognitive impairment in schizophrenia. J Psychopharmacol. 2015;29(2):178-96. doi: 10.1177/0269881114555252

12.Keefe RSE, Bilder RM, Davis SM, Harvey PD, Palmer BW, Gold JM, et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Arch Gen Psychiatry. 2007;64(6):633-47.

13.Javitt DC, Buchanan RW, Keefe RS, Kern R, McMahon RP, Green MF, et al. Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. Schizophr Res. 2012;136(1-3):25-31. doi: 10.1016/j.schres.2011.11.001

14.Buchanan RW, Keefe RS, Lieberman JA, Barch DM, Csernansky JG, Goff DC, et al. A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. Biol Psychiatry. 2011;69(5):442-9. doi: 10.1016/j.biopsych.2010.09.052

15.Wykes T, Huddy V, Cellard C, McGurk SR, Czobor P. A meta-analysis of cognitive remediation for schizophrenia: Methodology and effect sizes. Am J Psychiatry. 2011;168(5):472-85. doi: 10.1176/appi.ajp.2010.10060855

16.Wykes T, Spaulding WD. Thinking about the future cognitive remediation therapy-what works and could we do better? Schizophr Bull. 2011;37(Suppl 2):S80-90. doi: 10.1093/schbul/sbr064

17.Mahncke H, Kim SJ, Stasio C, Walker T, Buckley P, Caroff S. Results of an FDA device clearance trial for plasticity-based adaptive cognitive remediation (PACR). NPJ Schizophr. 2016;2:16007.

18.McGurk SR, Twamley EW, Sitzer DI, McHugo GJ, Mueser KT. A meta-analysis of cognitive remediation in schizophrenia. Am J Psychiatry. 2007;164(12):1791-802.

19.Medalia A, Saperstein AM. Does cognitive remediation for schizophrenia improve functional outcomes? Curr Opin Psychiatry. 2013;26(2):151-7.

20.Kimhy D, Vakhrusheva J, Bartels MN, Armstrong HF, Ballon JS, Khan S, et al. Aerobic fitness and body mass index in individuals with schizophrenia: Implications for neurocognition and daily functioning. Psychiatry Res. 2014;220(3):784-91.

21.Green MF, Horan WP, Lee J. Nonsocial and social cognition in schizophrenia: current evidence and future directions. World Psychiatry. 2019;18(2):146-61. doi: 10.1002/wps.20624

22.Hennigan A, O’Callaghan RM, Kelly AM. Neurotrophins and their receptors: roles in plasticity, neurodegeneration and neuroprotection. Biochem Soc Trans. 2007;35(Pt 2):424-7.

23.Vaynman S, Gomez-Pinilla F. License to run: Exercise impacts functional plasticity in the intact and injured central nervous system by using neurotrophins. Neurorehabil Neural Repair. 2005 Dec;19(4):283-95.

24.Binder DK, Scharfman H. Brain-Derived Neurotrofic Factor. Growth Factors. 2004;22(3):123-31. doi: 10.1080/08977190410001723308

25.Knaepen K, Goekint M, Heyman EM, Meeusen R. Neuroplasticity exercise-induced response of peripheral brain-derived neurotrophic factor: A systematic review of experimental studies in human subjects. Sports Med. 2010;40(9):765-801. doi: 10.2165/11534530-000000000-00000

26.Castrén E, Berninger B, Leingärtner A, Lindholm D. Chapter 6 Regulation of brain-derived neurotrophic factor mRNA levels in hippocampus by neuronal activity. Prog Brain Res. 1998;117:57-64.

27.Green MJ, Matheson SL, Shepherd A, Weickert CS, Carr VJ. Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Mol Psychiatry. 2011;16(9):960-72.

28.Buckley PF, Pillai A, Howell KR. Brain-derived neurotrophic factor: findings in schizophrenia. Curr Opin Psychiatry. 2011;24(2):122-7.

29.Zhang XY, Liang J, Chen DC, Xiu MH, De Yang F, Kosten TA, et al. Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia. Psychopharmacology. 2012;222(2):277-84. doi: 10.1007/s00213-012-2643-y

30.Rizos EN, Rontos I, Laskos E, Arsenis G, Michalopoulou PG, Vasilopoulos D, et al. Investigation of serum BDNF levels in drug-naive patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(5):1308-11. doi: 10.1016/j.pnpbp.2008.04.007

31.Ahmed AO, Mantini AM, Fridberg DJ, Buckley PF. Brain-derived neurotrophic factor (BDNF) and neurocognitive deficits in people with schizophrenia: A meta-analysis. Psychiatry Res. 2015;226(1):1-13. doi: 10.1016/j.psychres.2014.12.069

32.Johnston MV. Plasticity in the developing brain: implications for rehabilitation. Dev Disabil Res Rev. 2009;15(2):94-101.

33.Voss MW, Erickson KI, Prakash RS, Chaddock L, Kim JS, Alves H, et al. Neurobiological markers of exercise-related brain plasticity in older adults. Brain Behav Immun. 2013;28:90-9.

34.Voss MW, Vivar C, Kramer AF, van Praag H. Bridging animal and human models of exercise-induced brain plasticity. Trends Cogn Sci. 2013;17(10):525-44.

35.Maurus I, Hasan A, Röh A, Takahashi S, Rauchmann B, Keeser D, et al. Neurobiological effects of aerobic exercise, with a focus on patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2019;269(5):499-515. doi: 10.1007/s00406-019-01025-w

36.Rasmussen P, Brassard P, Adser H, Pedersen MV, Leick L, Hart E, et al. Evidence for a release of brain-derived neurotrophic factor from the brain during exercise. Exp Physiol. 2009;94(10):1062-9. doi: 10.1113/expphysiol.2009.048512

37.Seifert T, Brassard P, Wissenberg M, Rasmussen P, Nordby P, Stallknecht B, et al. Endurance training enhances BDNF release from the human brain. Am J Physiol Regul Integr Comp Physiol. 2010;298(2):R372-7. doi: 10.1152/ajpregu.00525.2009

38.Szuhany KL, Bugatti M, Otto MW. A meta-analytic review of the effects of exercise on brain-derived neurotrophic factor. J Psychiatr Res. 2015;60:56-64.

39.Gomez-Pinilla F, Hillman C. The influence of exercise on cognitive abilities. Compr Physiol. 2013;3(1):403-28.

40.van Praag H, Kempermann G, Gage FH. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. Nat Neurosci. 1999;2(3):266-70.

41.Brown J, Cooper-Kuhn CM, Kempermann G, Van Praag H, Winkler J, Gage FH, et al. Enriched environment and physical activity stimulate hippocampal but not olfactory bulb neurogenesis. Eur J Neurosci. 2003;17(10):2042-6.

42.Eadie BD, Redila VA, Christie BR. Voluntary exercise alters the cytoarchitecture of the adult dentate gyrus by increasing cellular proliferation, dendritic complexity, and spine density. J Comp Neurol. 2005;486(1):39-47.

43.Kleim JA, Cooper NR, VandenBerg PM. Exercise induces angiogenesis but does not alter movement representations within rat motor cortex. Brain Res. 2002;934(1):1-6.

44.Black JE, Isaacs KR, Anderson BJ, Alcantara AA, Greenough WT. Learning causes synaptogenesis, whereas motor activity causes angiogenesis, in cerebellar cortex of adult rats. Proc Natl Acad Sci U S A. 1990;87(14):5568-72.

45.Lopez-Lopez C, LeRoith D, Torres-Aleman I. Insulin-like growth factor I is required for vessel remodeling in the adult brain. Proc Natl Acad Sci U S A. 2004;101(26):9833-8.

46.Ding Y, Li J, Luan X, Ding YH, Lai Q, Rafols JA, et al. Exercise pre-conditioning reduces brain damage in ischemic rats that may be associated with regional angiogenesis and cellular overexpression of neurotrophin. Neuroscience. 2004;124(3):583-91.

47.Stroth S, Hille K, Spitzer M, Reinhardt R. Aerobic endurance exercise benefits memory and affect in young adults. Neuropsychol Rehabil. 2009;19(2):223-43.

48.Angevaren M, Aufdemkampe G, Verhaar HJ, Aleman A, Vanhees L. Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst Rev. 2008;(2):CD005381.

49.Themanson JR, Pontifex MB, Hillman CH. Fitness and action monitoring: evidence for improved cognitive flexibility in young adults. Neuroscience. 2008;157(2):319-28.

50.Hansen AL, Johnsen BH, Sollers JJ 3rd, Stenvik K, Thayer JF. Heart rate variability and its relation to prefrontal cognitive function: the effects of training and detraining. Eur J Appl Physiol. 2004;93(3):263-72.

51.Smith PJ, Blumenthal JA, Hoffman BM, Cooper H, Strauman TA, Welsh-Bohmer K, et al. Aerobic exercise and neurocognitive performance: a meta-analytic review of randomized controlled trials. Psychosom Med. 2010;72(3):239-52.

52.Colcombe SJ, Erickson KI, Scalf PE, Kim JS, Prakash R, McAuley E, et al. Aerobic exercise training increases brain volume in aging humans. J Gerontol Biol Sci Med Sci. 2006;61(11):1166-70.

53.Colcombe SJ, Kramer AF, McAuley E, Erickson KI, Scalf P. Neurocognitive aging and cardiovascular fitness: recent findings and future directions. J Mol Neurosci. 2004;24(1):9-14.

54.Colcombe SJ, Kramer AF, Erickson KI, Scalf P, McAuley E, Cohen NJ, et al. Cardiovascular fitness, cortical plasticity, and aging. Proc Natl Acad Sci U S A. 2004;101(9):3316-21.

55.Voss MW, Prakash RS, Erickson KI, Basak C, Chaddock L, Kim JS, et al. Plasticity of brain networks in a randomized intervention trial of exercise training in older adults. Front Aging Neurosci. 2010;2:32. doi: 10.3389/fnagi.2010.00032

56.Voss MW, Heo S, Prakash RS, Erickson KI, Alves H, Chaddock L, et al. The influence of aerobic fitness on cerebral white matter integrity and cognitive function in older adults: results of a one-year exercise intervention. Hum Brain Mapp. 2013;34(11):2972-85. doi: 10.1002/hbm.22119

57.Pereira AC, Huddleston DE, Brickman AM, Sosunov AA, Hen R, McKhann GM, et al. An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus. Proc Natl Acad Sci U S A. 2007;104(13):5638-43.

58.Kandola A, Hendrikse J, Lucassen PJ, Yücel M. Aerobic exercise as a tool to improve hippocampal plasticity and function in humans: Practical implications for mental health treatment. Front Hum Neurosci. 2016;10:373. doi: 10.3389/fnhum.2016.00373

59.Firth J, Cotter J, Carney R, Yung AR. The pro-cognitive mechanisms of physical exercise in people with schizophrenia. Br J Pharmacol. 2017;174(19):3161-72. doi: 10.1111/bph.13772

60.Campos C, Rocha NBF, Lattari E, Nardi AE, Machado S. Exercise Induced Neuroplasticity to Enhance Therapeutic Outcomes of Cognitive Remediation in Schizophrenia: Analyzing the Role of Brai nderived Neurotrophic Factor. CNS Neurol Disord Drug Targets. 2017;16(6):638-51. doi: 10.2174/1871527315666161223142918

61.Vancampfort D, Guelinckx H, Probst M, Ward PB, Rosenbaum S, Stubbs B, et al. Aerobic capacity is associated with global functioning in people with schizophrenia. J Ment Health. 2015;24(4):214-8.

62.Strassnig M, Brar JS, Ganguli R. Low cardiorespiratory fitness and physical functional capacity in obese patients with schizophrenia. Schizophr Res. 2011;126(1-3):103-9.

63.Scheewe TW, Backx FJ, Takken T, Jorg F, van Strater AC, Kroes AG, et al. Exercise therapy improves mental and physical health in schizophrenia: a randomised controlled trial. Acta Psychiatr Scand. 2013;127(6):464-73.

64.Scheewe TW, van Haren NE, Sarkisyan G, Schnack HG, Brouwer RM, de Glint M, et al. Exercise therapy, cardiorespiratory fitness and their effect on brain volumes: a randomised controlled trial in patients with schizophrenia and healthy controls. Eur Neuropsychopharmacol. 2013;23(7):675-85.

65.Firth J, Cotter J, Elliott R, French P, Yung AR. A systematic review and meta-analysis of exercise interventions in schizophrenia patients. Psychol Med. 2015;45(7):1343-61.

66.Rosenbaum S, Watkins A, Teasdale S, Curtis J, Samaras K, Kalucy M, et al. Aerobic exercise capacity: an important correlate of psychosocial function in first episode psychosis. Acta Psychiatr Scand. 2015;131(3):234.

67.Gorczynski P, Faulkner G. Exercise therapy for schizophrenia. Cochrane Database Syst Rev. 2010;(5):CD004412.

68.Firth J, Stubbs B, Rosenbaum S, Vancampfort D, Malchow B, Schuch F, et al. Aerobic exercise improves cognitive functioning in people with schizophrenia: A systematic review and meta-analysis. Schizophr Bull. 2017;43(3):546-56. doi: 10.1093/schbul/sbw115

69.Firth J, Carney R, Elliott R, French P, Parker S, McIntyre R, et al. Exercise as an intervention for first-episode psychosis: a feasibility study. Early Interv Psychiatry. 2018;12(3):307-15. doi: 10.1111/eip.12329

70.Duraiswamy G, Thirthalli J, Nagendra HR, Gangadhar BN. Yoga therapy as an add-on treatment in the management of patients with schizophrenia—A randomized controlled trial. Acta Psychiatr Scand. 2007;116(3):226-32

71.Varambally S, Thirthalli J, Venkatasubramanian G, Subbakrishna D, Gangadhar B, Jagannathan A, et al. Therapeutic efficacy of add-on yogasana intervention in stabilized outpatient schizophrenia: Randomized controlled comparison with exercise and waitlist. Indian J Psychiatry. 2012;54(3):227-32. doi: 10.4103/0019-5545.102414

72.Lee EHM, Hui CLM, Chang WC, Chan SKW, Li YK, Lee JTM, et al. Impact of physical activity on functioning of patients with first-episode psychosis—A 6months prospective longitudinal study. Schizophr Res. 2013;150(2-3):538-41. doi: 10.1016/j.schres.2013.08.034

73.Rosenbaum S, Tiedemann A, Sherrington C, Curtis J, Ward PB. Physical activity interventions for people with mental illness: A systematic review and meta-analysis. J Clin Psychiatry. 2014;75(9):964-74. doi: 10.4088/JCP.13r08765

74.Kimhy D, Vakhrusheva J, Bartels MN, Armstrong HF, Ballon JS, Khan S, et al. The Impact of Aerobic Exercise on Brain-Derived Neurotrophic Factor and Neurocognition in Individuals With Schizophrenia: A Single-Blind, Randomized Clinical Trial. Schizophr Bull. 2015;41(4):859-68.

75.Vancampfort D, Rosenbaum S, Probst M, Soundy A, Mitchell AJ, De Hert M, et al. Promotion of cardiorespiratory fitness in schizophrenia: a clinical overview and meta-analysis. Acta Psychiatr Scand. 2015;132(2):131-43. doi: 10.1111/acps.12407

76.Sloan RP, Shapiro PA, DeMeersman RE, Bagiella E, Brondolo EN, McKinley PS, et al. The effect of aerobic training and cardiac autonomic regulation in young adults. Am J Public Health. 2009;99(5):921-8.

77.Armstrong HF, Bartels MN, Paslavski O, Cain D, Shoval HA, Ballon JS, et al. The impact of aerobic exercise training on cardiopulmonary functioning in individuals with schizophrenia. Schizophr Res. 2016;173(1-2):116-7.

78.Kimhy D, Lauriola V, Bartels MN, Armstrong HF, Vakhrusheva J, Ballon JS, et al. Aerobic exercise for cognitive deficits in schizophrenia—The impact of frequency, duration, and fidelity with target training intensity. Schizophr Res. 2016;172(1-3):213-5.

79.Kimhy D, Khan S, Ayanrouh L, Chang RW, Hansen MC, Lister A, et al. Use of Active-Play Video Games to Enhance Aerobic Fitness in Schizophrenia: Feasibility, Safety, and Adherence. Psychiatr Serv. 2016;67(2):240-3.

80.Perraton LG, Kumar S, Machotka Z. Exercise parameters in the treatment of clinical depression: a systematic review of randomized controlled trials. J Eval Clin Pr. 2010;16(3):597-604.

81.Morgan MA, Coates MJ, Dunbar JA, Reddy P, Schlicht K, Fuller J. The TrueBlue model of collaborative care using practice nurses as case managers for depression alongside diabetes or heart disease: a randomised trial. BMJ Open. 2013;3(1). doi: 10.1136/bmjopen-2012-002171

82.Lieberman DA, Chamberlin B, Medina Jr. E, Franklin BA, Sanner BM, Vafiadis DK, et al. The power of play: Innovations in Getting Active Summit 2011: a science panel proceedings report from the American Heart Association. Circulation. 2011;123(21):2507-16.

83.Lanningham-Foster L, Foster RC, McCrady SK, Jensen TB, Mitre N, Levine JA. Activity-promoting video games and increased energy expenditure. J Pediatr. 2009;154(6):819-23.

84.Graves LE, Ridgers ND, Williams K, Stratton G, Atkinson G, Cable NT. The physiological cost and enjoyment of Wii Fit in adolescents, young adults, and older adults. J Phys Act Health. 2010;7(3):393-401.

85.Guderian B, Borreson LA, Sletten LE, Cable K, Stecker TP, Probst MA, et al. The cardiovascular and metabolic responses to Wii Fit video game playing in middle-aged and older adults. J Sports Med Phys Fit. 2010;50(4):436-42.

86.Miyachi M, Yamamoto K, Ohkawara K, Tanaka S. METs in adults while playing active video games: a metabolic chamber study. Med Sci Sports Exerc. 2010;42(6):1149-53.

87.Karvonen MJ, Kentala E, Mustala O. The effects of training on heart rate; a longitudinal study. Ann Med Exp Biol Fenn. 1957;35(3):307-15.

88.Ory M, Resnick B, Jordan PJ, Coday M, Riebe D, Ewing Garber C, et al. Screening, safety, and adverse events in physical activity interventions: collaborative experiences from the behavior change consortium. Ann Behav Med. 2005;29(Suppl):20-8.

89.Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc. 2011;43(7):1334-59.

90.Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, et al. The MATRICS consensus cognitive battery, part 1: Test selection, reliability, and validity. Am J Psychiatry. 2008;165(2):203-13. doi: 10.1176/appi.ajp.2007.07010042

91.Fisher M, Holland C, Subramaniam K, Vinogradov S. Neuroplasticity-based cognitive training in schizophrenia: An interim report on the effects 6 months later. Schizophr Bull. 2010;36(4):869-79. doi: 10.1093/schbul/sbn170

92.Kern RS, Gold JM, Dickinson D, Green MF, Nuechterlein KH, Baade LE, et al. The MCCB impairment profile for schizophrenia outpatients: Results from the MATRICS psychometric and standardization study. Schizophr Res. 2011 Mar;126(1-3):124-31. doi: 10.1016/j.schres.2010.11.008

93.Hufford MR, Davis VG, Hilt D, Dgetluck N, Geffen Y, Loebel A, et al. Circadian rhythms in cognitive functioning among patients with schizophrenia: Impact on signal detection in clinical trials of potential pro-cognitive therapies. Schizophr Res. 2014 Oct;159(1):205-10. doi: 10.1016/j.schres.2014.07.018

94.Borg G. Borgs perceived exertion and pain scales. Champaign (US): Human Kinetics; 1998.

95.Schneider LC, Struening EL. SLOF: a behavioral rating scale for assessing the mentally ill. Soc Work Res Abstr. 1983 Fall;19(3):9-21.

96.Harvey PD. Assessment of everyday functioning in schizophrenia. Innov Clin Neurosci. 2011;8(5):21-4.

97.Harvey PD, Ogasa M, Cucchiaro J, Loebel A, Keefe RSE. Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone. Schizophr Res. 2011;127(1-3):188-94. doi: 10.1016/j.schres.2011.01.004

98.Harvey PD, Raykov T, Twamley EW, Vella L, Heaton RK, Patterson TL. Validating the measurement of real-world functional outcomes: Phase I results of the VALERO study. Am J Psychiatry. 2011;168(11):1195-201. doi: 10.1176/appi.ajp.2011.10121723

99.Patterson TL, Goldman S, McKibbin CL, Hughs T, Jeste DV. UCSD Performance-Based Skills Assessment: Development of a New Measure of Everyday Functioning for Severely Mentally Ill Adults. Schizophr Bull. 2001;27(2):235-45.

100.Keefe RSE, Poe M, Walker TM, Kang JW, Harvey PD. The schizophrenia cognition rating scale: An interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity. Am J Psychiatry. 2006;163(3):426-32.

101.Mausbach BT, Bowie CR, Harvey PD, Twamley EW, Goldman SR, Jeste DV, et al. Usefulness of the UCSD performance-based skills assessment (UPSA) for predicting residential independence in patients with chronic schizophrenia. J Psychiatr Res. 2008;42(4):320-7.

102.Mausbach BT, Moore R, Bowie C, Cardenas V, Patterson TL. A Review of instruments for measuring functional recovery in those diagnosed with psychosis. Schizophr Bull. 2009;35(2):307-18.

103.Elliott CS, Fiszdon JM. Comparison of self-report and performance-based measures of everyday functioning in individuals with schizophrenia: Implications for measure selection. Cogn Neuropsychiatry. 2014;19(6):485-94. doi: 10.1080/13546805.2014.922062

104.Keefe RSE, Meltzer HA, Dgetluck N, Gawryl M, Koenig G, Moebius HJ, et al. Randomized, Double-Blind, Placebo-controlled study of encenicline, an α7 nicotinic acetylcholine receptor agonist, as a treatment for cognitive impairment in schizophrenia. Neuropsychopharmacology. 2015;40(13):3053-60. doi: 10.1038/npp.2015.176

105.Keefe RSE, Davis VG, Spagnola NB, Hilt D, Dgetluck N, Ruse S, et al. Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale. Eur Neuropsychopharmacol. 2015;25(2):176-84. doi: 10.1016/j.euroneuro.2014.06.009

106.Vita A, Deste G, Barlati S, De Peri L, Giambra A, Poli R, et al. Interview-based assessment of cognition in schizophrenia: Applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care. Schizophr Res. 2013;146(1-3):217-23. doi: 10.1016/j.schres.2013.02.035

107.Maffioletti E, Zanardini R, Gennarelli M, Bocchio-Chiavetto L. Influence of clotting duration on brain-derived neurotrophic factor (BDNF) dosage in serum. Biotechniques. 2014;57(3):111-4.

108.First MB, Gibbon M. The Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) and the Structured Clinical Interview for DSM-IV Axis II Disorders (SCID-II). Comprehensive Handbook of Psychological Assessment, Personality Assessment. In: Hilsenroth MJ, Segal DL, editors. Comprehensive handbook of psychological assessment. Vol. 2. Personality assessment. Hoboken(US): John Wiley & Sons Inc.; 2004. p. 134-43.

109.Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261-76.

110.Beck AT, Steer RA, Brown GK. Manual for the Beck depression inventory-II. New York (US): San Antonio TX Psychol Corp; 1996.

111.Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381-95.

112.Trost SG, Loprinzi PD, Moore R, Pfeiffer KA. Comparison of accelerometer cut points for predicting activity intensity in youth. Med Sci Sports Exerc. 2011;43(7):1360-8.

113.Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193-213.

114.Waters F, Naik N, Rock D. Sleep, fatigue, and functional health in psychotic patients. Schizophr Res Treat. 2013;2013:425826.

115.Afonso P, Figueira ML, Paiva T. Sleep-wake patterns in schizophrenia patients compared to healthy controls. World J Biol Psychiatry. 2014;15(7):517-24.

116.Belenky G, Wesensten NJ, Thorne DR, Thomas ML, Sing HC, Redmond DP, et al. Patterns of performance degradation and restoration during sleep restriction and subsequent recovery: a sleep dose-response study. J Sleep Res. 2003;12(1):1-12.

117.Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom K‐O. The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86(9):1119-27.

118.Benowitz NL, Kuyt F, Jacob P III. Circadian blood nicotine concentrations during cigarette smoking. Clin Pharmacol Ther. 1982;32(6):758-64.

119.Benowitz NL, Jacob P III, Jones RT, Rosenberg J. Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. J Pharmacol Exp Ther. 1982;221(2):368-72.

120.Allen MH, Debanne M, Lazignac C, Adam E, Dickinson LM, Damsa C. Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: a double-blind, randomized, placebo-controlled study. Am J Psychiatry. 2011;168(4):395-9.

121.Beck AT, Steer RA. Beck Anxiety Inventory Manual. In: Kreutzer JS, DeLuca J, Caplan B, editors. Encyclopedia of Clinical Neuropsychology. New York (US): Springer; 1990.

122.Bagby RM, Parker JDA, Taylor GJ. The twenty-item Toronto Alexithymia scale-I. Item selection and cross-validation of the factor structure. J Psychosom Res. 1994;38(1):23-32.

123.Gross JJ, John OP. Individual Differences in Two Emotion Regulation Processes: Implications for Affect, Relationships, and Well-Being. J Pers Soc Psychol. 2003;85(2):348-62.

124.Giles GE, Cantelon JA, Eddy MD, Brunyé TT, Urry HL, Mahoney CR, et al. Habitual exercise is associated with cognitive control and cognitive reappraisal success. Exp Brain Res. 2017;235(12):3785-97. doi: 10.1007/s00221-017-5098-x

125.Kimhy D, Vakhrusheva J, Jobson-Ahmed L, Tarrier N, Malaspina D, Gross JJ. Emotion awareness and regulation in individuals with schizophrenia: Implications for social functioning. Psychiatry Res. 2012;200(2-3):193-201. doi: 10.1016/j.psychres.2012.05.029

126.Diener E, Emmons RA, Larsem RJ, Griffin S. The Satisfaction With Life Scale. J Pers Assess. 1985;49(1):71-5.

127.Wu CH, Wu CY. Life satisfaction in persons with schizophrenia living in the community. Validation of the satisfaction with life scale. Soc Indic Res. 2008;85(3):447-60. https://doi.org/10.1007/s11205-007-9136-0

128.Bernstein DP, Ahluvalia T, Pogge D, Handelsman L. Validity of the childhood trauma questionnaire in an adolescent psychiatric population. J Am Acad Child Adolesc Psychiatry. 1997;36(3):340-8.

129.Mondelli V, Cattaneo A, Murri MB, Forti M Di, Handley R, Hepgul N, et al. Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: A pathway to smaller hippocampal volume. J Clin Psychiatry. 2011;72(12):1677-84. doi: 10.4088/JCP.10m06745

130.Guy W. ECDEU Assessment Manual for Psychopharmacology: Revised. Rockville (US): National Institute of Mental Health; 1976. p. 76-338.

131.Wechsler D. Wechsler Test of Adult Reading: WTAR. New York (US): Psychological Corporation; 2001.

132.August SM, Kiwanuka JN, McMahon RP, Gold JM. The MATRICS Consensus Cognitive Battery (MCCB): Clinical and cognitive correlates. Schizophr Res. 2012;134(1):76-82. doi: 10.1016/j.schres.2011.10.015

133.Rajji TK, Voineskos AN, Butters MA, Miranda D, Arenovich T, Menon M, et al. Cognitive performance of individuals with schizophrenia across seven decades: A study using the MATRICS consensus cognitive battery. Am J Geriatr Psychiatry. 2013;21(2):108-18.

134.McEvoy JP, Byerly M, Hamer RM, Dominik R, Swartz MS, Rosenheck RA, et al. Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: A randomized clinical trial. JAMA. 2014;311(19):1978-87. doi: 10.1001/jama.2014.4310

135.Kogan S, Ospina LH, Kimhy D. Inflammation in individuals with schizophrenia - Implications for neurocognition and daily function. Brain Behav Immun. 2018;74:296-9. doi: 10.1016/j.bbi.2018.09.016

136.Kogan S, Ospina LH, Mittal VA, Kimhy D. The impact of inflammation on neurocognition and risk for psychosis: a critical review. Eur Arch Psychiatry Clin Neurosci. 2019. doi: 10.1007/s00406-019-01073-2

137.Muthén LK, Muthén BO. Mplus User’s Guide. Eighth Edition. Los Angel (US): Muthén Muthén; 2017.

138.Strassnig MT, Signorile JF, Potiaumpai M, Romero MA, Gonzalez C, Czaja S, et al. High velocity circuit resistance training improves cognition, psychiatric symptoms and neuromuscular performance in overweight outpatients with severe mental illness. Psychiatry Res. 2015;229(1-2):295-301. doi: 10.1016/j.psychres.2015.07.007

139.Lin J, Chan S

引用本文

Luz H. Ospina,Melanie Wall,Lars F. Jarskog,Jacob S. Ballon,Joseph McEvoy,Matthew N. Bartels,Richard Buchsbaum,Richard P. Sloan,T. Scott Stroup,David Kimhy*. Improving Cognition via Exercise (ICE): Study Protocol for a Multi-Site, Parallel-Group, Single-Blind, Randomized Clinical Trial Examining the Efficacy of Aerobic Exercise to Improve Neurocognition, Daily Functioning, and Biomarkers of Cognitive Change in, Journal of Psychiatry and Brain Science. 2019; 4; (6). https://doi.org/10.20900/jpbs.20190020.

文献评论

相关学者

相关机构